Angiopoietin-2 and Growth Differentiation Factor-15 as Predictors of Device-Detected Atrial Fibrillation Burden
Biomedicines. 2026 Apr 16;14(4):902. doi: 10.3390/biomedicines14040902.
PMID:
Hemagglutination inhibition and alternate serologic responses following Influenza A(H3N2) virus infection
medRxiv [Preprint]. 2026 Apr 22:2026.04.21.26351404. doi: 10.64898/2026.04.21.26351404.
PMID:
A TRAC-478-adjuvanted recombinant N1 neuraminidase influenza virus vaccine induces balanced and broadly protective immune responses
NPJ Vaccines. 2026 May 2. doi: 10.1038/s41541-026-01456-2. Online ahead of print.
PMID:
Local B cell immunity and durable memory after live-attenuated influenza intranasal vaccination of humans
Sci Transl Med. 2026 Apr 29;18(847):eadz8439. doi: 10.1126/scitranslmed.adz8439. Epub 2026 Apr 29.
PMID:
Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer
Nat Commun. 2026 Apr 25. doi: 10.1038/s41467-026-72204-2. Online ahead of print.
PMID:
Influenza B mosaic HA mRNA-LNP vaccines are cross-reactive and protective in mice
Mol Ther Nucleic Acids. 2026 Mar 30;37(2):102921. doi: 10.1016/j.omtn.2026.102921. eCollection 2026 Jun 16.
PMID:
B lymphocyte protein factories produced by hematopoietic stem cell gene editing
Science. 2026 Apr 16;392(6795):eadz8994. doi: 10.1126/science.adz8994. Epub 2026 Apr 16.
PMID:
Imaging and safety profiling of inhaled siRNA RyR2 in human respiratory models
Arch Toxicol. 2026 Apr 15. doi: 10.1007/s00204-026-04370-7. Online ahead of print.
PMID:
Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies
mBio. 2026 May 13;17(5):e0044526. doi: 10.1128/mbio.00445-26. Epub 2026 Apr 13.
PMID:
Meeting Report: Fourth Correlates of Protection for Next Generation Influenza Vaccines
Influenza Other Respir Viruses. 2026 Apr;20(4):e70258. doi: 10.1111/irv.70258.
PMID: